机构:[1]Hebei Med Univ, Hosp 4, Dept Endocrinol, Shijiazhuang 050011, Peoples R China临床科室内分泌科河北医科大学第四医院[2]Hebei Med Univ, Dept Immunol, Key Lab Immune Mech & Intervent Serious Dis Hebei, Shijiazhuang 050017, Peoples R China[3]Bethune Int Peace Hosp, Dept Med Oncol, Shijiazhuang 050082, Peoples R China[4]First Hosp Shijiazhuang City, Dept Med Oncol, Shijiazhuang 050011, Peoples R China
Objective: To investigate the correlations between the polymorphism of IGF2BP2, a diabetes predisposing gene, and breast cancer risk in Chinese female with Han nationality. Method: The genomic DNAs were extracted from the peripheral blood drawn from 564 female breast cancer patients and 394 healthy females of Han nationality. The polymorphism of IGF2BP2 gene rs4402960 was detected by a multiplex PCR-Ligase detection reaction (PCR-LDR) assay from genomic DNA. The correlations between genotype and breast cancer risk as well as clinicopathologic characteristics were compared. Results: The differences are significant between genotype distribution of IGF2BP2 gene rs4402960 (P = 0.009) and allele gene frequency from both disease and control groups. Both T gene carriers (GT + TT) (OR = 1.462; 95% CI, 1.127-1.897) and T allele gene (OR = 1.382; 95% CI, 1.116-1.710) significantly increase the risk of breast cancer. No considerable correlations were observed between the polymorphism of rs4402960 and the clinical pathological parameters, such as age at diagnosis, lymphatic metastasis, estrogen and progesterone receptor status, cerb-B2 receptor status, and tumor staging. Conclusions: The IGF2BP2 gene rs4402960 polymorphism increases the breast cancer risk of Chinese females with Han nationality, and is a breast cancer predisposing gene. (C) 2014 Elsevier Masson SAS. All rights reserved.
基金:
Natural Science Foundation of Hebei Province of ChinaNatural Science Foundation of Hebei Province [H2013505059]; Department of Science and Technology of Hebei Province of China [12396107D, 14397707D]; Wu Jieping Foundation [320.6750.12604, 320.6750.14063]; Health and Family Planning Commission of Hebei [20110466]
语种:
外文
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2015]版:
大类|4 区医学
小类|4 区医学:研究与实验4 区药学
最新[2025]版:
大类|2 区医学
小类|2 区医学:研究与实验2 区药学
JCR分区:
出版当年[2015]版:
Q3MEDICINE, RESEARCH & EXPERIMENTALQ3PHARMACOLOGY & PHARMACY
最新[2024]版:
Q1MEDICINE, RESEARCH & EXPERIMENTALQ1PHARMACOLOGY & PHARMACY
第一作者机构:[1]Hebei Med Univ, Hosp 4, Dept Endocrinol, Shijiazhuang 050011, Peoples R China
通讯作者:
通讯机构:[2]Hebei Med Univ, Dept Immunol, Key Lab Immune Mech & Intervent Serious Dis Hebei, Shijiazhuang 050017, Peoples R China[3]Bethune Int Peace Hosp, Dept Med Oncol, Shijiazhuang 050082, Peoples R China[*1]Key Laboratory of Immune Mechanism and Intervention on Serious Disease in Hebei Province, Department of Immunology, Hebei Medical University, Shijiazhuang 050017, China.
推荐引用方式(GB/T 7714):
Liu Guihong,Zhu Tienian,Cui Yujie,et al.Correlation between IGF2BP2 gene polymorphism and the risk of breast cancer in Chinese Han women[J].BIOMEDICINE & PHARMACOTHERAPY.2015,69:297-300.doi:10.1016/j.biopha.2014.12.017.
APA:
Liu, Guihong,Zhu, Tienian,Cui, Yujie,Liu, Jingpu,Liu, Jiankun...&Zhao, Ruijing.(2015).Correlation between IGF2BP2 gene polymorphism and the risk of breast cancer in Chinese Han women.BIOMEDICINE & PHARMACOTHERAPY,69,
MLA:
Liu, Guihong,et al."Correlation between IGF2BP2 gene polymorphism and the risk of breast cancer in Chinese Han women".BIOMEDICINE & PHARMACOTHERAPY 69.(2015):297-300